Uday Popat Selected Research

Uday Popat Research Topics

Disease

29	Neoplasms (Cancer) 02/2024 - 04/2003
27	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2023 - 04/2007
21	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 05/2022 - 04/2007
18	Graft vs Host Disease (Graft-Versus-Host Disease) 02/2024 - 04/2007
17	Multiple Myeloma 12/2021 - 06/2006
15	Primary Myelofibrosis (Myelosclerosis) 01/2023 - 05/2005
14	Hematologic Neoplasms (Hematological Malignancy) 03/2024 - 07/2010
12	Leukemia 03/2024 - 04/2003
11	Hodgkin Disease (Hodgkin's Disease) 01/2022 - 07/2011
9	Lymphoma (Lymphomas) 01/2023 - 06/2009
9	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 12/2020 - 01/2009
6	Non-Hodgkin Lymphoma (Lymphosarcoma) 12/2023 - 06/2009
6	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022 - 04/2012
5	Multiple Sclerosis 09/2021 - 05/2004
5	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2019 - 04/2003
5	Myeloid Leukemia (Leukemia, Myelocytic) 11/2018 - 06/2011
4	Residual Neoplasm 01/2020 - 08/2014
3	Hemorrhagic Cystitis 01/2021 - 07/2010
3	Thrombocytopenia (Thrombopenia) 01/2021 - 01/2013
3	Disease Progression 01/2018 - 05/2004
3	Chromosome Aberrations (Chromosome Abnormalities) 07/2017 - 09/2007
3	Infections 02/2017 - 07/2010
3	Body Weight (Weight, Body) 04/2014 - 12/2012
2	Frailty 10/2023 - 04/2007
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2023 - 09/2008
2	Relapsing-Remitting Multiple Sclerosis 09/2021 - 02/2015
2	Pathologic Complete Response 11/2020 - 01/2020
2	Aplastic Anemia (Anemia, Hypoplastic) 06/2019 - 08/2016
2	Immunoglobulin Light-chain Amyloidosis 11/2018 - 08/2015
2	Mucositis 06/2017 - 01/2016
2	Dermatitis 06/2017 - 01/2016
2	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 05/2017 - 10/2014
2	Renal Insufficiency (Renal Failure) 12/2016 - 07/2009
2	Pure Red-Cell Aplasia 05/2016 - 03/2013
2	Systemic Mastocytosis 01/2016 - 10/2014
2	Bronchiolitis Obliterans Syndrome 01/2016 - 01/2006
2	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 09/2013 - 04/2009
2	Philadelphia Chromosome 04/2012 - 01/2005
2	Blast Crisis (Blast Phase) 03/2011 - 09/2008
1	B-Cell Lymphoma (Lymphoma, B Cell) 11/2023

Drug/Important Bio-Agent (IBA)

20	Busulfan (Busulfex)FDA Link 01/2022 - 03/2011
17	fludarabineIBA 01/2022 - 04/2007
16	Melphalan (Alkeran)FDA LinkGeneric 12/2021 - 04/2007
9	Cyclophosphamide (Cytoxan)FDA LinkGeneric 08/2022 - 06/2011
8	Tacrolimus (Prograf)FDA LinkGeneric 11/2016 - 04/2007
6	Clofarabine (Clolar)FDA Link 01/2022 - 06/2011
6	AntigensIBA 01/2018 - 06/2011
6	Rituximab (Mabthera)FDA Link 01/2016 - 09/2008
5	Tyrosine Kinase InhibitorsIBA 01/2020 - 03/2011
4	Alkylating AgentsIBA 02/2024 - 11/2018
4	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 01/2016
4	venetoclaxIBA 01/2023 - 01/2022
4	Cytarabine (Cytosar-U)FDA LinkGeneric 05/2022 - 09/2013
4	Gemcitabine FDA Link 01/2018 - 11/2012
4	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 05/2016 - 01/2010
4	CD40 Ligand (CD40L)IBA 02/2006 - 04/2003
3	Vorinostat FDA Link 01/2022 - 11/2015
3	Decitabine FDA Link 01/2022 - 11/2018
3	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 01/2020 - 07/2011
3	Ferritins (Ferritin)IBA 11/2016 - 01/2009
3	Methotrexate (Mexate)FDA LinkGeneric 05/2015 - 04/2007
3	VaccinesIBA 02/2006 - 04/2003
2	Drug CombinationsIBA 03/2024 - 11/2015
2	NucleosidesIBA 01/2023 - 10/2016
2	Janus Kinase InhibitorsIBA 01/2021 - 06/2015
2	Azacitidine (5 Azacytidine)FDA Link 11/2020 - 01/2016
2	FM 100 (FM100)IBA 01/2019 - 01/2019
2	EnzymesIBA 11/2018 - 05/2015
2	FucosyltransferasesIBA 11/2018 - 05/2015
2	Janus Kinase 1IBA 03/2016 - 01/2016
2	Janus KinasesIBA 03/2016 - 11/2015
2	Ifosfamide FDA LinkGeneric 02/2016 - 06/2011
2	Bortezomib (Velcade)FDA Link 02/2016 - 07/2011
2	Etoposide (VP 16)FDA LinkGeneric 02/2016 - 06/2011
2	Proteins (Proteins, Gene)FDA Link 01/2016 - 04/2003
2	plerixafor FDA Link 07/2015 - 09/2013
2	HLA Antigens (Human Leukocyte Antigens)IBA 12/2014 - 06/2011
2	Dihydrotachysterol (AT 10)IBA 11/2014 - 06/2011
2	thymoglobulin FDA Link 05/2012 - 06/2011
2	Imatinib Mesylate (Gleevec)FDA Link 03/2011 - 01/2009
2	CytokinesIBA 06/2009 - 05/2004
2	Interleukin-2 (IL2)IBA 02/2006 - 10/2005
2	Neoplasm Antigens (Tumor Antigens)IBA 10/2005 - 04/2003
1	Inotuzumab OzogamicinIBA 02/2024
1	NivolumabIBA 02/2024

Therapy/Procedure

52	Hematopoietic Stem Cell Transplantation 02/2024 - 05/2005
44	Stem Cell Transplantation 12/2023 - 05/2004
35	Cell Transplantation 03/2024 - 04/2011
33	Transplantation 01/2023 - 09/2004
27	Therapeutics 03/2024 - 01/2005
23	Drug Therapy (Chemotherapy) 11/2023 - 06/2003
4	Homologous Transplantation 01/2019 - 09/2009
4	Immunotherapy 02/2006 - 04/2003
3	Induction Chemotherapy 04/2014 - 09/2008
2	Haploidentical Transplantation 12/2019 - 01/2018
2	Autologous Transplantation 02/2017 - 04/2009
2	Aftercare (After-Treatment) 10/2016 - 08/2015
2	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 08/2016 - 06/2011
2	Hematopoietic Stem Cell Mobilization 06/2011 - 06/2009
1	Preoperative Exercise 01/2024